WallStreetZenWallStreetZen
Analyst Ranking
Top 2%
#74 out of 4529 analysts
Average Return
+15.57%
Win Rate
49%129 out of 265
Risk vs Reward
Poor
Good

Douglas Tsao's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+324.99%$14.36$61.02
2023-06-12 -
2024-03-28
Buy
Praxis Precision Medicines IncPRAX
+319.38%$14.55$61.02
2023-11-15 -
2024-03-28
Buy
Praxis Precision Medicines IncPRAX
+319.38%$14.55$61.02
2023-08-09 -
2024-03-28
Buy
Cabaletta Bio IncCABA
+313.27%$1.96$8.10
2022-03-18 -
2023-03-17
Buy
Praxis Precision Medicines IncPRAX
+306.80%$15.00$61.02
2023-04-14 -
2024-03-28
Buy

Douglas Tsao Analyst Color

Get additional color on Douglas Tsao's coverage of popular stocks

Douglas Tsao's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Argenx SeARGX
21Buy$451.00+14.55%Maintains
2 days ago
Praxis Precision Medicines IncPRAX
14Buy$105.00+72.07%Reiterates
3 days ago
Marinus Pharmaceuticals IncMRNS
12Buy$27.00+198.67%Reiterates
3 days ago
Disc Medicine IncIRON
4Buy$70.00+12.43%Maintains
7 days ago
Cabaletta Bio IncCABA
14Buy$30.00+75.85%Maintains
7 days ago
Coherus Biosciences IncCHRS
16Buy$11.00+360.25%Maintains
9 days ago
Crinetics Pharmaceuticals IncCRNX
14Buy$60.00+28.18%Maintains
9 days ago
Scpharmaceuticals IncSCPH
8Buy$18.00+258.57%Reiterates
15 days ago
Protagonist Therapeutics IncPTGX
13Buy$38.00+31.35%Maintains
18 days ago
Trevena IncTRVN
7Buy$9.00+1,856.52%Reiterates
18 days ago
Evolus IncEOLS
12Buy$27.00+92.86%Reiterates
21 days ago
Rezolute IncRZLT
8Buy$14.00+449.02%Reiterates
22 days ago
Biohaven LtdBHVN
2Buy$63.00+15.19%Maintains
25 days ago
Viridian Therapeutics IncVRDN
8Buy$37.00+111.31%Reiterates
a month ago
Revance Therapeutics IncRVNC
16Buy$12.00+143.90%Reiterates
a month ago
Apellis Pharmaceuticals IncAPLS
17Buy$92.00+56.52%Reiterates
a month ago
Minerva Neurosciences IncNERV
10Hold$11.00+326.36%Reiterates
a month ago
Sage Therapeutics IncSAGE
10Hold$28.00+49.41%Maintains
a month ago
Roivant Sciences LtdROIV
9Buy$17.00+61.29%Maintains
a month ago
Immunovant IncIMVT
14Buy$51.00+57.85%Maintains
3 months ago
Cerevel Therapeutics Holdings IncCERE
6Hold$45.00+6.46%Downgrades
4 months ago
Dare Bioscience IncDARE
10Buy$6.00+1,124.49%Maintains
5 months ago
Outlook Therapeutics IncOTLK
10Buy$40.00+235.01%Maintains
5 months ago
EVO
5Buy$14.00+53.68%Maintains
7 months ago
Rvl Pharmaceuticals PLCRVLPQ
3Buy$3.00+10,614.29%Maintains
7 months ago
Aeon Biopharma IncAEON
1Buy$18.00+55.17%Initiates Coverage On
7 months ago
Theravance Biopharma IncTBPH
7Buy$20.00+122.97%Reiterates
8 months ago
Alkermes PLCALKS
8Hold$34.00+25.60%Reiterates
8 months ago
Eliem Therapeutics IncELYM
2Hold$6.00N/AReiterates
a year ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$74.00N/AInitiates Coverage On
a year ago
Therapeuticsmd IncTXMD
5Hold$10.00N/ADowngrades
2 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
4HoldN/AN/ADowngrades
2 years ago
Histogen IncHSTO
2Buy$30.00N/AMaintains
2 years ago
Amryt Pharma PLCAMYT
2Buy$18.00N/AMaintains
2 years ago
Radius Health IncRDUS1
5Hold$10.00N/AMaintains
2 years ago
Gw Pharmaceuticals PLCGWPH
3Hold$220.00N/ADowngrades
3 years ago
Amag Pharmaceuticals IncAMAG
2Hold$13.75N/ADowngrades
3 years ago
Momenta Pharmaceuticals IncMNTA
4Hold$52.50N/ADowngrades
4 years ago
Chiasma IncCHMA
2Buy$10.00N/AMaintains
4 years ago
Dermira IncDERM2
1Hold$18.75N/ADowngrades
4 years ago
Icon PLCICLR
3Hold$148.00N/AMaintains
5 years ago
Teva Pharmaceutical Industries LtdTEVA
5Hold$23.00N/AMaintains
6 years ago
Pacira Biosciences IncPCRX
1Strong Buy$50.00N/AMaintains
6 years ago
Phibro Animal Health CorpPAHC
1Strong Sell$33.00N/AMaintains
6 years ago
Pfenex IncPFNX
1Strong Buy$8.00N/AMaintains
6 years ago
Endo International PLCENDPQ
1Hold$10.00N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.